Constant Therapy Health has reported that its ‘digital therapy’ is proving useful for stroke survivors in clinical trials.
The company specialises in digital therapeutics for stroke survivors, as well a dementia patients and those who have suffered from traumatic brain injuries.
It has now revealed the positive results of a 10-week clinical trial which suggests that digital alternatives can have better results for stroke survivors than traditional paper techniques.
At the completion of the trial, patients receiving its Constant Therapy (CT-R) demonstrated an average improvement of 6.75 points on the WAB Aphasia Quotient versus the control group showing an average improvement of only 0.38 points.
CT-R adjusts therapy difficulty automatically, progressing patients based on their task performance and neurological profile using artificial intelligence.
According to Dr. Swathi Kiran, Constant Therapy Health founding scientist and professor of neurorehabilitation at the Sargent College of Health and Rehabilitation Sciences at Boston University: “This trial demonstrates the power of digital therapy to enable stroke survivors to recover cognitive and speech abilities more effectively compared to traditional paper-based modalities.
“Its significance is heightened during the COVID-19 pandemic that has increased health risks and raised other barriers for patients needing this crucial therapy to continue their recovery journeys.”
Meanwhile, Veera Anantha, CEO of Constant Therapy Health, added: “Post-stroke survivors who often require sustained rehabilitation and communication practice, face significant burdens in accessing therapy due to shortages in qualified clinicians, insurance limitations and geographic access.
“Digital therapy removes these barriers and enables patients to receive consistent therapy remotely anyplace and anytime via a computer or mobile device.”